nfr-logonfr-logo
PROSJEKTBANKEN
Switch to English
Se statistikken
Se prosjektene

0 antall prosjekter

Dato fra ny til gammel

ERC-European Research Council (ERC)

Targeting Acute Leukemia with TdT-TCR-T-cell therapy

The aim of this PoC project is to commercialize new therapy for acute lymphoblastic leukemia (ALL) developed in context of my ERC consolidator grant. T-cell receptors (TCRs) have in recent years emerged as promising therapeutic molecules in cell- and gene-therapy of cancer. I have completed the p...

Tildelt: kr 1,7 mill.

Prosjektperiode: 2023-2025

Sted: Akershus og 2 andre

CL1-Health

PRecisIon Cancer MEdicine RepurpOsing SystEm Using Pragmatic Clinical Trials

Millions of people in the EU are negatively affected by cancer, and cancer is one of the leading causes of death and morbidity in Europe (ecis.jrc.europa.eu). The PRIME-ROSE consortium will contribute to the Mission Cancer goal to optimise treatment and support quality of life of more than 3 mill...

Tildelt: kr 18,2 mill.

Prosjektperiode: 2023-2028

Sted: Oslo

MSCA-Marie Sklodowska-Curie Actions (MSCA)

Guiding glioblastoma treatments by decrypting tumor biomechanics via Magnetic Resonance Elastography.

Guiding glioblastoma treatments by decrypting tumor biomechanics via Magnetic Resonance Elastography.

Tildelt: kr 2,9 mill.

Prosjektperiode: 2023-2026

Sted: Oslo

CL1-Health

Developing and implementing innovative Patient-Centred Care Pathways for cancer patients

In the EU, 2.7M people were diagnosed with and 1.3M died of cancer in 2020. Over 12M people have survived cancer, thanks to advances in early detection and new therapies. With higher cure rates and more patients living longer with cancer, access to patient-centred care consisting of optimal suppo...

Tildelt: kr 22,9 mill.

Prosjektperiode: 2022-2027

Sted: Akershus og 3 andre

CL1-Health

Dual screening by Spectral Artificial Visual Examination (SAVE) for Female Genital Schistosomiasis (FGS) and cervical cancer. Digital, new, low-cost, and simple screening and training.

Dual screening by Spectral Artificial Visual Examination (SAVE) for Female Genital Schistosomiasis (FGS) and cervical cancer. Digital, new, low-cost, and simple screening and training.

Tildelt: kr 34,8 mill.

Prosjektperiode: 2022-2026

Sted: Agder og 2 andre

H20-MSCA-Marie Sklodowska-Curie actions

SWIPT- MED: Simultaneous Wireless Information and Power Transfer for Medical Implants

The growth and extensible research in active implantable medical devices (AIMDs) have provided the opportunity for continuous and remote monitoring of patients with chronic illness. But the major technological challenge is that most of the implants operate on batteries with limited durability. It...

Tildelt: kr 3,0 mill.

Prosjektperiode: 2021-2024

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Intelligent digital tools for screening of brain connectivity and dementia risk estimation in people affected by mild cognitive impairment.

Intelligent digital tools for screening of brain connectivity and dementia risk estimation in people affected by mild cognitive impairment.

Tildelt: kr 64,0 mill.

Prosjektperiode: 2021-2026

Sted: Oslo og 2 andre

H20-MSCA-Marie Sklodowska-Curie actions

Multiparametric imaging of glioblastoma tumour heterogeneity for supporting treatment decisions and accurate prognostic estimation

Glioblastoma is not only the most frequent but also the most malignant tumour originating in the Central Nervous System. Due to the extremely complex and heterogeneous molecular biology of this tumour “the same treatment for all” approach does not work well in this disease, and standard of care i...

Tildelt: kr 2,1 mill.

Prosjektperiode: 2019-2021

Sted: Oslo

H20-FET-Future and Emerging Technologies

Fluorescence and Reactive oxygen Intermediates by Neutron Generated electronic Excitation as a foundation for radically new cancer therapies

Fluorescence and Reactive oxygen Intermediates by Neutron Generated electronic Excitation as a foundation for radically new cancer therapies

Tildelt: kr 18,8 mill.

Prosjektperiode: 2019-2024

Sted: Oslo og 2 andre

H20-ERC-European Research Council

Imaging Perfusion Restrictions from Extracellular Solid Stress

Imaging Perfusion Restrictions from Extracellular Solid Stress

Tildelt: kr 14,0 mill.

Prosjektperiode: 2018-2023

Sted: Oslo

H20-MSCA-Marie Sklodowska-Curie actions

High Performance Soft-tissue Navigation

High Performance Soft-tissue Navigation

Tildelt: kr 15,0 mill.

Prosjektperiode: 2016-2021

Sted: Oslo og 2 andre

H20-FET-Future and Emerging Technologies

A paradigm shift in cancer therapy – using mitochondria-powered chemiluminescence to non-invasively treat inaccessible tumours

Brain cancers such as glioblastoma multiforme (GBM) are practically incurable due to their location, invasiveness and highly aggressive nature. The use of light-based treatments of GBM by activating tumor-localized photosensitizers, such as in photodynamic therapy (PDT) has been clinically evalua...

Tildelt: kr 14,5 mill.

Prosjektperiode: 2016-2022

Sted: Oslo

H20-MSCA-Marie Sklodowska-Curie actions

Wireless In-Body Environment

WiBEC (Wireless In-Body Environment Communications) is an Innovative Training Network for 16 young researchers, who will be recruited and trained in coordinated manner by Academia, Industry, and Medical Centres. This training will address the Social, Health, and Technology challenges of the H2020...

Tildelt: kr 12,2 mill.

Prosjektperiode: 2016-2019

Sted: Oslo og 2 andre

1